prebiotics-and-probiotics

MEET US - BioActor Presenting MicrobiomeX® and Naxus® at the 15th Annual IPC conference

MEET US – BioActor Presenting MicrobiomeX® and Naxus® at the 15th Annual IPC conference

Maastricht, The Netherlands, June 16th, 2022

Press release
The 15th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health – IPC2022 will be held during 27 – 30 June 2022 in Bratislava. BioActor is an active contributor and confirmed partner of this conference. Hans van der Saag (CEO) will present on our ingredient Naxus®, a prebiotic with metabolic and immune effects, and Yala Stevens (CSO) presents the clinical and mechanistic research on MicrobiomeX® in irritable bowel syndrome (IBS) patients and elderly subjects.

prebiotics-and-probiotics

BioActor Presenting MicrobiomeX® and Naxus® at the 15th Annual IPC conference

The 15th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health – IPC2022 will be held during 27 – 30 June 2022 in Bratislava.

The IPC conference is the world’s biggest scientific conference that focuses solely on basic and applied research of probiotics, prebiotics, gut microbiota and health. More than 400 scientists from over more than 80 countries have attended the conference last season.

The scientific program will focus on current advances in the research, production and use of probiotics and prebiotics with particular focus on their role in maintaining health and preventing diseases. At IPC, leading scientists from industry and academia present current advances in understanding and influencing the interaction between gut microbiota and human health.

The conference enables the interactive exchange of state-of-the-art knowledge. It is focused on evidence-based benefits, health claims proven in scientific experiments and clinical trials.

BioActor is an active contributor and confirmed partner of this conference. Hans van der Saag (CEO) will present on our ingredient Naxus®, a prebiotic with metabolic and immune effects, and Yala Stevens (CSO) presents the clinical and mechanistic research on MicrobiomeX® in irritable bowel syndrome (IBS) patients and elderly subjects.

Naxus® presentation by Hans van der Saag (CEO)

Naxus® is a native arabinoxylan extract from the wheat endosperm. It is a powerful and well-tolerated prebiotic with metabolic and immune effects. Due to its complex branched structure, Naxus® is slowly and selectively fermented by multiple species of the microbiota, inducing a remarkable bifidogenic effect without causing gas formation and intestinal discomfort. It induces a remarkable microbiota shift and increased short-chain fatty acids production, with proven effects on immune health and glycemic control.

MicrobiomeX® presentation by Yala Stevens (CSO)

MicrobiomeX® is a natural extract from citrus fruit designed to beneficially modulate the microbiome composition in the gut. It’s a first-in-class Flavobiotic® that protects the gut barrier and directly leverages the gut microbiome’s potential. This results in enhanced immune health, as well as anti-inflammatory effects.

IBS is a functional gastrointestinal disorder with various symptoms including pain and discomfort in the abdomen. Also, elderly often develop imbalances in their gut microbiota and often experience discomfort.

Patients with IBS and elderly would benefit substantially from treatments that could relieve their symptoms and improve their gut health. The flavonoids in MicrobiomeX® have the potential to benefit individuals with gastrointestinal conditions because of its antioxidant and anti-inflammatory properties.

Business opportunities

The IPC conference is a great opportunity to reconnect with colleagues from all over the world and make new contacts. Hans van der Saag (CEO) and Yala Stevens (CSO) will be there to represent BioActor’s portfolio, with a focus on our gut health ingredients. Feel free to pass by at any time to chat about our innovative ingredients for gut health support!

We look forward to meeting you in Bratislava!

The IPC 2022 conference will take place from 27 to 30 June 2022.

Where: Hviezdoslavovo námestie 3, 811 02 Bratislava, Slovakia

About BioActor

BioActor, based in Maastricht, Netherlands, is a product development company that supplies proprietary bioactive formulations to the nutrition & healthcare industry. The company focuses on the development of innovative bioactives that address active living and healthy ageing. The goal is to provide the nutrition & healthcare industry with science-based innovations that confer a real health benefit to the consumer.

For further information, see www.bioactor.com or visit https://microbiomex.com/ or https://naxus.nl/


Menopausal-bone-health

8 Ingredients proven to improve bone health during (post)menopause

8 Ingredients proven to improve bone health during (post)menopause

June 13th, 2022

Bone health is crucial to maintain, particularly after menopause. Consumption of dietary supplements, especially in post-menopausal women is on the rise, as advances in research are made and proven benefits are elucidated. Here we mention some of the ingredients that have demonstrated the ability to support women during menopause – specifically for the loss and maintenance of bone mineral density! You will also learn about which foods contain these ingredients, how they are beneficial to bone health and their recommended daily intake.

Menopausal-bone-health

Bone health, menopause, and dietary supplements

Menopause is the permanent cessation of menstruation naturally occurring in females at an average age of 51 [1].

Importantly, menopause leads to a decrease in estrogen levels and consequently increases bone loss. Estrogen is a hormone responsible for menstruation and known to have protective effects on bone loss and reduce inflammation.

Bone tissue in women is generally thinner than in men, and bone density has been reported to markedly decrease after menopause (post-menopause). Women can lose up to 20% of their bone density in just 5-7 years due to these hormonal shifts and experience increased joint pain [2].

The rise in the use of dietary supplements, especially by post-menopausal women, who are at risk of bone loss, is growing tremendously as advances in research are made, and the benefits of multiple natural ingredients are proven [3].

8 ingredients to sustain bone health in menopause.

Calcium & Vitamin D

Calcium is a critical component of bone architecture necessary for the deposition of bone minerals. Around 99% of calcium is stored in bones and teeth, making them strong and hard [4].

Vitamin D is vital for regulating intestinal calcium absorption and stimulating bone resorption to maintain serum calcium concentration [5]. There are, however, substances that can interfere with the body’s ability to use calcium, such as oxalate, protein, phytate, and caffeine.

Examples of foods rich in calcium include dairy, soybeans, and green leafy vegetables. While the predominant way of ascertaining vitamin D is through our own body’s synthesis stimulated by sufficient sunlight exposure on our skin. Thus, supplementation of vitamin D3, cholecalciferol, is advocated during autumn and winter due to limited sunlight availability, depending on geography.

Women under the age of 50 should consume a daily dosage of 1000mg of Calcium and 400-800IU Vitamin D, while women above the age of 50 should consume 1200mg of calcium and 800-1000IU of vitamin D daily [6].

Joint-health

Vitamin C, B9 and B12, K

Vitamin C is important in stimulating the differentiation of osteoblasts, cells that synthesize bone matrix and coordinate bone mineralization [7].

Antioxidant effects of vitamin C have also been reported to reduce bones from cell damage and may improve left ventricular diastolic function which menopausal women often experience a dramatic reduction in [8]. Foods rich in vitamin C include citrus fruits, bell peppers, broccoli, and strawberries.

Vitamin B9 (folate) and B12 are major determinants of homocysteine levels. Thus, a deficiency in vitamin B9 and B12 leads to increased homocysteine levels, which have been associated with impaired bone health and osteoporosis, a condition concerning weak and brittle bones [9].

Vitamin B9 and B12 have also been reported to assist with reducing the severity and duration of hot flashes and other menopause symptoms [10]. Therefore, increasing folate and B12 levels through foods such as pulses, legumes, beans, brown rice and, you guessed it, leafy green vegetables, can improve bone health.

Moreover, vitamin K has been reported to assist with reducing hot flashes and other menopause symptoms [11].

The recommended daily amount for adult women according to the National Institutes of Health for vitamin C is 75mg; for vitamin B9 is 400mcg DFE; for vitamin B12 is 2.4mcg and ultimately for vitamin K is 90mcg [12].

Quercetin

Quercetin is the bioactive compound abundantly found in citrus fruits, green leafy vegetables, and onions. Studies show that onions reduce bone loss due to their anti-inflammatory and antioxidant flavonoid, quercetin [13].

Quercetin inhibits the genesis and differentiation of osteoclasts, preserving bone mass and health. Bone mineral density in postmenopausal women has also been reported to improve when supplementing with onion juice [14].

Quercetin at a dose of 150 mg has been shown to improve bone-health metrics, which is around three servings of onion [15]. Note, quercetin is found in the pigment and outer layer of the onion, with red and yellow ones thus having higher concentrations.

Bonolive® (olive leaf extract 40% oleuropein)

Bonolive® is an ingredient derived from olive leaf and rich in the most abundant olive polyphenol, oleuropein, tailored to women to counteract bone loss risk associated with menopause.

Clinical research in post-menopausal women has demonstrated that 12 months of supplementation with 250mg of Bonolive® is able to increase osteocalcin levels by 32%, promote the activity of osteoblasts (the bone-building cells), and decrease osteoclast activity involved in the breakdown and resorption of bone [16,17]. Thus the clinical dosage of 250mg is recommended.

Moreover, after 12 months, the Bonolive® treatment group displayed a significant protection against bone loss, compared to the placebo group.

Additionally, chondrocytes, important for cartilage-building, are also increased while cartilage degeneration is inhibited through oleuropein. Further benefits can be ascribed to oleuropein’s anti-oxidant and anti-inflammatory properties.

Oleuropein can be found in olive oil and olive leaf, although in limited quantities and therefore, supplementation with a high-quality, standardized extract such as Bonolive® is a more convenient method of consuming this nutrient in adequate quantities.

Improve bone health during menopause

In conclusion, a well-balanced diet rich in vitamins, minerals and antioxidants, together with the right supplementations may help ameliorate bone health during menopause and promote healthy ageing and active living.


BioActor-showcasing-WATTS’UP-at-the-19th-Annual-ISSN-Conference

MEET US - BioActor showcasing WATTS’UP® at the 19th Annual ISSN Conference

MEET US – BioActor showcasing WATTS’UP® at the 19th Annual ISSN Conference

Maastricht, The Netherlands, June 3rd, 2022

Press release
The International Society of Sports Nutrition (ISSN) is organizing their 19th Annual Conference and Expo. BioActor is an active contributor to this conference and Yala Stevens, our chief scientific officer will present the clinical results on our ingredient WATTS’UP®.

BioActor-showcasing-WATTS’UP-at-the-19th-Annual-ISSN-Conference

BioActor showcasing WATTS’UP® at the 19th Annual ISSN Conference

The International Society of Sports Nutrition (ISSN) is the world’s leader in providing science-based sports nutrition and supplement information. This year they are organizing their 19th Annual Conference and Expo. Anyone interested in sports science/nutrition can attend!

The conference addresses a diverse audience such as researchers, students, dieticians, sports nutritionists, but also the athletes themselves. Therefore, the conference offers a platform to discuss various hot topics related to sports nutrition, such as sports supplements, elucidation of the physiological mechanisms behind nutraceutical interventions, as well as nutritional effects on performance.

The strength of the annual ISSN conference is that top researchers present on novel paradigms in sports nutrition. Besides, it is also an excellent opportunity to make new contacts and reconnect with colleagues from all over the world.

BioActor is an active contributor to this conference, since Yala Stevens, our chief scientific officer will present the clinical results on our ingredient WATTS’UP®. Title of the study: The effect of citrus flavonoid extract supplementation on anaerobic capacity in moderately trained athletes: a randomized controlled trial.

Original research paper presentation by Yala Stevens (CSO)

Previous studies have demonstrated that supplementation with flavonoids from citrus fruits may be an effective strategy to improve exercise performance in male athletes. Repeated intake of 500 mg of a specific citrus fruit extract improved aerobic exercise performance. Also, an increased absolute power output and a decreased oxygen consumption/power ratio were observed.

Yala will be presenting new insights on the beneficial effects of 400 mg and 500 mg citrus fruit extract (WATTS’UP®) supplementation on short-term high-intensity exercise performance. In this study, we used a WinGate protocol, the gold standard for testing high-intensity performance for 92 male and female participants.

Join us on Friday 17th of June at 10:10am for Yala’s presentation in the Westin Fort Lauderdale Beach Resort (Florida).

Business opportunities

BioActor will also be present with a small table top, together with the exclusive distributor for the US market, SEPPIC Inc. Jeremie Feuer (SEPPIC) and Joris Kretzers (BioActor) will be there to represent BioActor’s portfolio, with a specific focus on our sports nutrition ingredients. If you are looking for natural ingredients that benefit athlete’s performance, feel free to pass by at any time on Thursday or Friday for a chat!

We look forward to meeting you in Fort Lauderdale!

The ISSN conference and expo will take place from June, 16-18 2022.
Westin Fort Lauderdale Beach Resort, 321 North Fort Lauderdale Beach Blvd., Fort Lauderdale Florida USA 33304

About BioActor

BioActor, based in Maastricht, Netherlands, is a product development company that supplies proprietary bioactive formulations to the nutrition & healthcare industry. The company focuses on the development of innovative bioactives that address active living and healthy ageing. The goal is to provide the nutrition & healthcare industry with science-based innovations that confer a real health benefit to the consumer.

For further information, see www.bioactor.com or visit www.wattsup.eu


MicrobiomeX® nominated as finalist for 2022 NutraIngredients-USA ‘Ingredient of the Year’

MicrobiomeX® nominated as finalist for 2022 NutraIngredients-USA ‘Ingredient of the Year’

Maastricht, Netherlands, June 2nd, 2022

Press release
BioActor is delighted to share that MicrobiomeX® was nominated as a finalist for the 2022 NutraIngredients-USA ‘Ingredient of the Year’ in the category Prebiotic. NutraIngredients-USA Awards honour the best and brightest in ingredients, finished products, companies, people and initiatives in the nutrition and dietary supplements industry.

MicrobiomeX-is-a-finalist-for-the-NutraIngredients-Awards

Finalist for 2022 NutraIngredients-USA ‘Ingredient of the Year’

We are excited to announce that MicrobiomeX® was nominated as a finalist for the 2022 NutraIngredients-USA ‘Ingredient of the Year’ in the category Prebiotic.

The NutraIngredients brand has led the online news source in the nutrition industry for over 19 years, providing insights into the functional food and supplement market in North America, ranging from investments and innovation to ingredients, product formulation, regulation, consumer trends and more!

Specifically, NutraIngredients-USA Awards honour the best and brightest in ingredients, finished products, companies, people and initiatives in the nutrition and dietary supplements industry. With a focus on innovation, long-term market success and state-of-the-art research, it is an honour that MicrobiomeX® was nominated a finalist!

MicrobiomeX® is a first-in-class Flavobiotic® that has been clinically proven to improve the SCFA profile, lower gut inflammation and enhance immunity through its precision prebiotic effect. Beneficial changes in the microbiota are induced at a low dose of 250-500 mg, and MicrobiomeX® is stable with probiotics.

“Special thanks goes out to our US distributor SEPPIC with whom we collaborated to get there”, says Joris Kretzers, Sales Manager Western Europe & North America of BioActor. “We are very proud of this achievement and are looking forward to the winner announcement in July!”

About BioActor

BioActor, based at the Maastricht Health Campus, Netherlands, is a life science company that has developed a range of proprietary bioactive ingredients for the nutrition & consumer health industries. The company focuses on the development of plant-based health ingredients for active living and healthy ageing. The goal is to provide the nutrition & consumer health industries with clinically tested innovations that confer a real health benefit to the consumer.

Feel free to contact BioActor via info@bioactor.com for more information on the possibilities MicrobiomeX® has to offer.

Further information can be found on:  www.microbiomex.com and www.bioactor.com